Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ginger + tangerine refers to a combination of ginger (Zingiber officinale) and tangerine (Citrus reticulata), typically used as a dietary supplement, herbal tea blend, or ingredient in food and beverages. This combination is not an approved pharmaceutical drug but is commonly marketed for its potential health benefits such as digestive support, anti-inflammatory effects, and immune system enhancement. Ginger contains bioactive compounds like gingerols that may have antiemetic and anti-inflammatory properties. Tangerine provides vitamin C and flavonoids with antioxidant activity. There is some early research suggesting that combinations including ginger and the pith of Citrus tangerine may help reduce symptoms related to alcohol consumption[2]. The mechanism of action primarily involves modulation of inflammatory pathways, antioxidant effects, mild antiplatelet activity (ginger), and possible enhancement of gastrointestinal motility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ginger + tangerine.